Patients’ adherence to diabetic therapeutic regimen in Nigeria

Olabisi Fatimo Ibitoye, R B Ibitoye, I Alako, M M Adamolekun


Introduction: An association between Intimate Partner Violence (IPV) against women and negative social and health consequences for children has been observed in multiple studies from around the world. Impaired growth is an important health determinant in children and has been associated with higher morbidity and mortality in children less than 5 years of age. Different forms of violence have been shown to impair the growth of children in diverse countries, especially low-income countries. This study describes the relationship between maternal experience of IPV, maternal characteristics (age, parity, ethnicity, marital status and symptoms of depression) and subsequent child growth.

Methods: Existing data that utilized longitudinal study design to collect data from 207 mother-child dyads that were from a low socio-economic status was used for secondary data analysis. The child’s weight and length data were converted to WHO growth standard z scores (Weight for Length (WLZ) and Length for Age (LAZ)) at birth and at 24 months. The z scores were assessed in relation to women’s IPV exposure status and maternal characteristics.  Linear regression was used to assess the association between prenatal and postnatal maternal variables, child variables (gender and birth order) and child’s WLZ and LAZ.

Findings:There was no statistical significance in WLZ and LAZ in children who were exposed to maternal prenatal IPV and those not exposed. The following relationships were seen in male children: birth order (p=0.023) and WLZ; Symptoms of maternal depression during pregnancy (p=0.021) and WLZ at 24 months; symptoms of maternal depression after birth (p= 0.049) and WLZ at 24 months and exposure to postnatal violence (p=0.030), specifically emotional violence (p=0.050) and LAZ score. Female children whose mothers were not married had a low LAZ (p=0.009).

Conclusion:The growth of male children less than two years is vulnerable to exposure of maternal emotional violence and depression in the pre and postnatal period while height gain of female children is affected by maternal single status.

Recommendations: There is need to screen mothers for IPV, specifically emotional violence carefully monitor the growth patterns in their children after birth especially male children


Patients, Adherence, Diabetes, Therapeutic Regimen

Full Text:




Adisa, R., Fakeye, T. O., & Fasanmade, A. (2011). Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria. Pharmacy Practice, 9(2), 72.

Al-Qazaz, H. K., Sulaiman, S. A., Hassali, M. A., Shafie, A. A., Sundram, S., Al-Nuri, R., & Saleem, F. (2011). Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. International journal of clinical pharmacy, 33(6), 1028-1035.

Bagonza, J., Rutebemberwa, E., & Bazeyo, W. (2015). Adherence to anti-diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC health services research, 15(1), 168.

Bailey, G. R., Barner, J. C., Weems, J. K., Leckbee, G., Solis, R., Montemayor, D., & Pope, N. D. (2012). Assessing barriers to medication adherence in underserved patients with diabetes in Texas. The Diabetes Educator, 38(2), 271-279.

Basheti, I. A., El Hait, S. S., Qunaibi, E. A., Aburuz, S., & Bulatova, N. (2016). Associations between patient factors and medication adherence: A Jordanian experience. Pharmacy Practice (Granada), 14(1), 0-0.

Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International journal of clinical practice, 65(3), 314-322.

Brunner, L. S. (2010). Brunner & Suddarth's textbook of medical-surgical nursing (Vol. 1). Lippincott Williams & Wilkins.

Chaudhury, A., Duvoor, C., Dendi, R., Sena, V., Kraleti, S., Chada, A., & Kuriakose, K. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Frontiers in endocrinology, 8, 6.

Cutler, D. M., & Everett, W. (2010). Thinking outside the pillbox—medication adherence as a priority for health care reform. New England Journal of Medicine, 362(17), 1553-1555.

EI-Hadiyah, T. M., Madani, A. M., Abdelrahim, H. M., & Yousif, A. K. (2016). Factors affecting medication non-adherence in type 2 Sudanese diabetic patients. Pharmacology & Pharmacy, 7(04), 141.

Gelaw, B. K., Mohammed, A., Tegegne, G. T., Defersha, A. D., Fromsa, M., Tadesse, E., & Ahmed, M. (2014). Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital. Journal of diabetes research, 2014.

Hutchins, V., Zhang, B., Fleurence, R. L., Krishnarajah, G., & Graham, J. (2011). A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Current medical research and opinion, 27(6), 1157-1168.

International Diabetes Federation (IDF). Diabetes atlas. 7th ed.; 2015. http://

IDF Diabetes Atlas - 8th Edition

Jin, J., Sklar, G. E., Oh, V. M. S., & Li, S. C. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and clinical risk management, 4(1), 269.

Khan, A. R., Lateef, Z. N. A. A., Al Aithan, M. A., Bu-Khamseen, M. A., Al Ibrahim, I., & Khan, S. A. (2012). Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine, 19(1), 26.

Kalyango, J. N., Owino, E., & Nambuya, A. P. (2008). Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. African health sciences, 8(2).

Lee, J. M., Davis, M. M., Gebremariam, A., & Kim, C. (2010). Age and sex differences in hospitalizations associated with diabetes. Journal of Women's Health, 19(11), 2033-2042.

Monahan, P. O., Lane, K. A., Hayes, R. P., McHorney, C. A., & Marrero, D. G. (2009). Reliability and validity of an instrument for assessing patients’ perceptions about medications for diabetes: the PAM-D. Quality of Life Research, 18(7), 941.

Nam, S., Chesla, C., Stotts, N. A., Kroon, L., & Janson, S. L. (2011). Barriers to diabetes management: patient and provider factors. Diabetes research and clinical practice, 93(1), 1-9.

Nau, D. P. (2012). Recommendations for improving adherence to type 2 diabetes mellitus therapy—focus on optimizing oral and non-insulin therapies. American Journal of Managed Care, 18(3), S49.

Ogbera, A. O., Kuku, S., & Dada, O. (2012). The metabolic syndrome in thyroid disease: A report from Nigeria. Indian journal of endocrinology and metabolism, 16(3), 417.

Paes, A. H., Bakker, A., & Soe-Agnie, C. J. (1997). Impact of dosage frequency on patient compliance. Diabetes care, 20(10), 1512-1517.

Pollack, M. F., Purayidathil, F. W., Bolge, S. C., & Williams, S. A. (2010). Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes research and clinical practice, 87(2), 204-210.

Rwegerera, G. M., Moshomo, T., Gaenamong, M., Oyewo, T. A., Gollakota, S., Mhimbira, F. A., & Rivera, Y. P. (2018). Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alexandria journal of medicine, 54(2), 103-109.

Rwegerera, G. M. (2014). Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania-A cross-sectional study. The Pan African Medical Journal, 17.

Rickles, N. M., Noland, C. M., Tramontozzi, A., & Vinci, M. A. (2010). Pharmacy student knowledge and communication of medication errors. American Journal of Pharmaceutical Education, 74(4), 60.

Uchenna, O., Ijeoma, E., Pauline, E., & Sylvester, O. (2010). Contributory factors to diabetes dietary regimen non-adherence in adults with diabetes. World Acad Sci Eng Technol, 4(9), 644-51.

van Bruggen, R., Gorter, K., Stolk, R. P., Zuithoff, P., Klungel, O. H., & Rutten, G. E. (2009). Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiology and drug safety, 18(11), 983-991.

World Health Organisation. Global report on diabetes; 2016. Available at http://

WHO (2003) Adherence to Long-Term Therapies Evidence for Action

Wong, M., Kong, A. P., So, W. Y., Jiang, J. Y., Chan, J. C., & Griffiths, S. M. (2011). Adherence to oral hypoglycemic agents in 26 782 Chinese patients: a cohort study. The Journal of Clinical Pharmacology, 51(10), 1474-1482.


  • There are currently no refbacks.

Copyright (c) 2019 Kenyan Journal of Nursing & Midwifery

© Numid Publishers        ISSN:  2518-8631